
MEDIC
Streamlined cancer drug target discovery/validation by CRISPR functional genomics in cancer organoid models at scale.
Employees
Enterprise value
$20—30m
Authorizing premium user...
Streamlined cancer drug target discovery/validation by CRISPR functional genomics in cancer organoid models at scale.